Mometasone Furoate · MOMETASONE FUROATE 1 mg/mL · Lotion · Topical · Glenmark Pharmaceuticals Inc., USA
NDC 68462-0385-02 · 1 BOTTLE in 1 CARTON / 60 mL in 1 BOTTLE · ANDA · View full market →
Just 2 companies supply this market — thin enough that a single exit would be felt immediately. The price has held steady around $0.3759 per unit over the past year.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →Manufacturer list price as filed — not what pharmacies actually pay after discounts.
Not scored — fragility is computed for NADAC-priced NDCs.
sole-source market
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
No FDA shortage reports for this drug or its presentations.
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Encube Ethicals, Inc. | MOMETASONE FUROATE 1 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Glenmark Pharmaceuticals Inc., USA | MOMETASONE FUROATE 1 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
DrugDashboards, "Mometasone Furoate — NDC 68462-0385-02," retrieved September 3, 2026, https://drugdashboards.com/drug/68462038502.
Free to cite with attribution — see how the data is put together.